Acadia Pharmaceuticals Inc (ACAD) stock
ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3027% below fair value
$18.32−0.35 (-1.87%)
Close on Nov 17, 2026Market cap $3.16BP/E 8.3Yield –
Acadia Pharmaceuticals total assets
Total assets on the balance sheet at the end of each period.
Acadia Pharmaceuticals's total assets was $1.74B at Jun 30, 2026. For fiscal 2025 it was $1.56B, up 31.7% from the year before. Over ten years it grew 21.6% a year on average. The highest annual figure on record is $1.56B in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56B | +31.7% |
| FY2024 | Dec 31, 2024 | $1.19B | +58.6% |
| FY2023 | Dec 31, 2023 | $748.96M | +27.4% |
| FY2022 | Dec 31, 2022 | $587.81M | -16.0% |
| FY2021 | Dec 31, 2021 | $700.12M | -10.5% |
| FY2020 | Dec 31, 2020 | $782.62M | -0.1% |
| FY2019 | Dec 31, 2019 | $783.18M | +45.0% |
| FY2018 | Dec 31, 2018 | $540.20M | +40.5% |
| FY2017 | Dec 31, 2017 | $384.51M | -31.5% |
| FY2016 | Dec 31, 2016 | $561.15M | +152.9% |
| FY2015 | Dec 31, 2015 | $221.90M | -31.8% |
| FY2014 | Dec 31, 2014 | $325.46M | +72.1% |
| FY2013 | Dec 31, 2013 | $189.12M | +74.2% |
| FY2012 | Dec 31, 2012 | $108.59M | +238.1% |
| FY2011 | Dec 31, 2011 | $32.11M | -16.4% |
| FY2010 | Dec 31, 2010 | $38.39M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.74B | +42.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.61B | +41.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.56B | +31.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.33B | +36.2% |
| Q2 FY2025 | Jun 30, 2025 | $1.23B | +34.1% |
| Q1 FY2025 | Mar 31, 2025 | $1.13B | +32.4% |
| Q4 FY2024 | Dec 31, 2024 | $1.19B | +58.6% |
| Q3 FY2024 | Sep 30, 2024 | $976.87M | +54.4% |
| Q2 FY2024 | Jun 30, 2024 | $914.10M | +42.2% |
| Q1 FY2024 | Mar 31, 2024 | $855.10M | +30.5% |
| Q4 FY2023 | Dec 31, 2023 | $748.96M | +27.4% |
| Q3 FY2023 | Sep 30, 2023 | $632.54M | +5.0% |
| Q2 FY2023 | Jun 30, 2023 | $642.77M | +4.9% |
| Q1 FY2023 | Mar 31, 2023 | $655.31M | +5.0% |
| Q4 FY2022 | Dec 31, 2022 | $587.81M | -16.0% |
| Q3 FY2022 | Sep 30, 2022 | $602.49M | -16.0% |
| Q2 FY2022 | Jun 30, 2022 | $612.77M | -15.4% |
| Q1 FY2022 | Mar 31, 2022 | $624.25M | -17.3% |
| Q4 FY2021 | Dec 31, 2021 | $700.12M | -10.5% |
| Q3 FY2021 | Sep 30, 2021 | $717.67M | -9.8% |
| Q2 FY2021 | Jun 30, 2021 | $724.43M | -4.6% |
| Q1 FY2021 | Mar 31, 2021 | $755.17M | +1.0% |
| Q4 FY2020 | Dec 31, 2020 | $782.62M | -0.1% |
| Q3 FY2020 | Sep 30, 2020 | $795.66M | +3.9% |
| Q2 FY2020 | Jun 30, 2020 | $759.65M | +64.8% |
| Q1 FY2020 | Mar 31, 2020 | $747.45M | +49.2% |
| Q4 FY2019 | Dec 31, 2019 | $783.18M | +45.0% |
| Q3 FY2019 | Sep 30, 2019 | $765.59M | +187.3% |
| Q2 FY2019 | Jun 30, 2019 | $460.88M | +46.3% |
| Q1 FY2019 | Mar 31, 2019 | $501.11M | +42.7% |
| Q4 FY2018 | Dec 31, 2018 | $540.20M | +40.5% |
| Q3 FY2018 | Sep 30, 2018 | $266.46M | -35.6% |
| Q2 FY2018 | Jun 30, 2018 | $314.96M | -31.0% |
| Q1 FY2018 | Mar 31, 2018 | $351.04M | -30.2% |
| Q4 FY2017 | Dec 31, 2017 | $384.51M | -31.5% |
| Q3 FY2017 | Sep 30, 2017 | $413.71M | -33.0% |
| Q2 FY2017 | Jun 30, 2017 | $456.32M | – |
| Q1 FY2017 | Mar 31, 2017 | $503.01M | – |
| Q4 FY2016 | Dec 31, 2016 | $561.15M | – |
| Q3 FY2016 | Sep 30, 2016 | $617.38M | – |
See a number that looks wrong?